AcquisitionVimian announced the acquisition of AllAccem Inc., a US-based company focused on veterinary dental care, with an EBITDA margin well above group average.
Organic GrowthThe company achieved 5% organic growth at the group level, driven by increases in Specialty Pharma, Veterinary Services, and Diagnostics.
Stock ListingThe Listing Committee of Nasdaq Stockholm approved Vimian's application to be listed on the Nasdaq Stockholm Main Market in the Large Cap segment, which is expected to improve liquidity in the shares and elevate the company's profile.